Virtual Patient Groups for Sarcoidosis
(SupportSarc Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether Mindfulness-Based Cognitive Therapy (MBCT), a mental health treatment, can reduce fatigue and improve anxiety and depression in individuals with sarcoidosis, a condition causing lumps of inflammatory cells in the body. Participants will either join an 8-week virtual mindfulness program or a monthly virtual sarcoidosis support group to compare effectiveness in managing symptoms. Ideal candidates are those diagnosed with sarcoidosis who experience significant fatigue and have internet access. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance symptom management for sarcoidosis.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these virtual programs are safe for participants with sarcoidosis?
Research shows that mindfulness-based cognitive therapy (MBCT) is generally safe. Studies have found that patients with sarcoidosis who used online MBCT experienced reduced fatigue, anxiety, and depression. These studies reported no serious side effects, indicating that the therapy is well-tolerated. As a virtual program, it involves no medications or physical procedures, reducing the risk of side effects. This makes MBCT a low-risk option for those considering joining the trial.12345
Why are researchers excited about this trial?
Researchers are excited about the Virtual Mindfulness Based Cognitive Therapy Group for sarcoidosis because it offers a fresh approach to managing fatigue and mental health, which are significant concerns for patients. Unlike standard treatments that might focus on medication or physical therapy, this therapy emphasizes mindfulness techniques to improve mental well-being and reduce fatigue. The virtual format also provides a convenient and accessible way for patients to engage in therapy from the comfort of their homes, which is a significant advantage for those with limited mobility or access to healthcare facilities.
What evidence suggests that this trial's treatments could be effective for sarcoidosis?
Research has shown that Mindfulness-Based Cognitive Therapy (MBCT) can help reduce tiredness in people with sarcoidosis. In this trial, participants in the 8-week Virtual Mindfulness-Based Cognitive Therapy Group will meet weekly with a certified counselor to learn and practice mindfulness techniques. Studies have found that a 12-week online MBCT program can improve tiredness, anxiety, depression, and overall health in these patients. Another study discovered that even just one 45-minute session of mindfulness training could help lessen tiredness. These findings suggest that MBCT could be a promising way to improve mental well-being and manage tiredness in those with sarcoidosis.12678
Who Is on the Research Team?
Logan J Harper, MD
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with sarcoidosis experiencing fatigue, who may also have symptoms of anxiety or depression. Participants should be willing to engage in virtual sessions and complete surveys. Specific eligibility criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either an 8-week virtual MBCT program or join a monthly virtual support group
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Mindfulness Based Cognitive Therapy Group
- Virtual sarcoidosis support group
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Clinical and Translational Science Collaborative of Northern Ohio
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator